Clinical trial
MG98 in Treating Patients With Advanced Solid Tumors
NCT00003890 · NCIC Clinical Trials Group, Other · Completed
Key facts
| NCT number | NCT00003890 |
|---|---|
| Title | MG98 in Treating Patients With Advanced Solid Tumors |
| Official title | A Phase I Study of MG98 Given as a 2 Hour Twice Weekly IV Infusion in Patients With Advanced Cancer |
| Lead sponsor | NCIC Clinical Trials Group, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | MG 98 |
| Enrollment | 19 |
| Start date | Feb 22, 1999 |
| Primary completion | Sep 27, 2001 |
| Completion | Sep 22, 2008 |
| First posted | Aug 20, 2003 |
| Last update posted | Apr 6, 2020 |
| Countries | Canada, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: